PMID: 15247542Jul 13, 2004Paper

An update on neuroimaging of multiple sclerosis

Current Opinion in Neurology
Paul M Matthews

Abstract

The advent of magnetic resonance imaging provided a powerful tool for monitoring the dynamics of pathological changes in multiple sclerosis, but conventional approaches offer only limited information that is directly relevant to clinical progression. Continued developments of imaging methods and their use for diagnosis, monitoring pathology and understanding disease progression are reviewed here. Magnetic resonance imaging is now well established as a clinical test for multiple sclerosis, but the specific ways in which imaging information should best be incorporated into diagnostic criteria are still debated. New data defining the substantial pathology in grey matter, regional variation in the progression of pathology and the relationship between the spatial distribution of pathological changes and symptoms are providing an increasingly compelling description of changes relevant to disability. Molecular-imaging approaches promise much more detailed descriptions. Functional magnetic resonance imaging, which suggests that adaptive functional changes could limit clinical expression of pathology, are providing further clues to the link between measures of pathology and disability. New data further reinforce the view that pathology ...Continue Reading

References

Jul 17, 1999·Journal of Neurology, Neurosurgery, and Psychiatry·N EvangelouJ Palace
Jan 15, 2000·Neurology·H ReddyD L Arnold
Jan 22, 2000·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·G HelmsH Link
May 22, 2002·Brain Research·Joshua D Grill, David R Riddle
Jun 22, 2002·Brain : a Journal of Neurology·Patrizia PantanoGian Luigi Lenzi
Jul 18, 2002·Multiple Sclerosis : Clinical and Laboratory Research·A Cifelli, P M Matthews
Oct 29, 2002·Annals of Neurology·Alberto CifelliPaul M Matthews
Jan 23, 2003·Brain : a Journal of Neurology·M FilippiA Falini
Feb 1, 2003·Journal of the Neurological Sciences·Wolfgang BrückChristine Stadelmann
Feb 26, 2003·Neurology·Francois CottonCharles R G Guttmann
Mar 6, 2003·Multiple Sclerosis : Clinical and Laboratory Research·Benjamin TurnerLance D Blumhardt
May 14, 2003·Neurology·M P SormaniUNKNOWN European Study Group on Interferon Beta-1b in Secondary Progressive MS
May 20, 2003·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·J C DebruyneJ L De Reuck
Jun 14, 2003·Brain : a Journal of Neurology·Michael SailerAnders Dale
Jun 20, 2003·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·Matilde IngleseOded Gonen
Jun 25, 2003·Brain : a Journal of Neurology·Francesca BagnatoJoseph A Frank
Jun 25, 2003·Neurology·M WylezinskaP M Matthews
Jul 15, 2003·Current Opinion in Neurology·Massimo Filippi, Maria A Rocca
Jul 24, 2003·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·M RauschM Rudin
Aug 20, 2003·Archives of Neurology·Frederik BarkhofPaul van der Valk
Sep 10, 2003·Neurology·E M FrohmanUNKNOWN Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Sep 26, 2003·Journal of Magnetic Resonance Imaging : JMRI·Roland G HenryDaniel Pelletier
Oct 22, 2003·NeuroImage·Dominik S Meier, Charles R G Guttmann
Oct 31, 2003·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·T E J BehrensS M Smith
Feb 3, 2004·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·Nicola R SibsonDaniel C Anthony
Mar 30, 2004·Annals of Neurology·Christian EnzingerFranz Fazekas

❮ Previous
Next ❯

Citations

Feb 21, 2002·Neurologic Clinics·A B Ben-Zacharia, F D Lublin
Sep 22, 2010·Schizophrenia Bulletin·Thomas J WhitfordMartha E Shenton
Jul 1, 2006·Expert Opinion on Drug Discovery·Paul M Matthews, Richard G Wise
Oct 3, 2006·NeuroImage·David RessBrian Wandell
Sep 20, 2005·Lancet Neurology·Christian Enzinger, Franz Fazekas

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.